Internal Medicine, Medical Oncology · Saint Louis, MO
NPI
1316965759
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4921 Parkview Pl, Div Im Medical Oncology, Ste 7a, 7b, 7c
Saint Louis, MO, 63110
Phone (800) 647-2098
Groups this clinician bills Medicare through
Medicare paid, 2024
$848K
34,167 services
Medicare patients, 2024
698
Average age 73
Drug cost, 2024
$7.7M
2,596 prescriptions
Company payments, 2025
$16K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nancy L Bartlett was code J9271 (injection, pembrolizumab, 1 mg), 3,800 times for 13 patients. In total Nancy L Bartlett billed 34,167 services in 127 codes, and Medicare paid $848K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 3,800 | 13 | $44.23 | $168K |
| Q5115 Injection, rituximab-abbs, biosimilar, (truxima), 10 mg | Office | 1,490 | 16 | $25.68 | $38K |
| 99214 Office E&M - Established | Office | 981 | 425 | $90.34 | $89K |
| J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Office | 770 | 13 | $38.43 | $30K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 770 | 53 | $0.09 | $69.38 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 540 | 45 | $0.76 | $408 |
| 36415 Venipuncture Blood Collection | Office | 390 | 261 | $8.65 | $3,374 |
| J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | Office | 288 | 21 | $68.68 | $20K |
| J9190 Injection, fluorouracil, 500 mg | Office | 178 | 11 | $2.38 | $423 |
| 96413 Chemotherapy Administration | Office | 166 | 121 | $87.29 | $14K |
| 99213 Office E&M - Established | Office | 164 | 136 | $65.65 | $11K |
| 96375 Injection Administration | Office | 136 | 71 | $11.45 | $1,557 |
| 96415 Chemotherapy Administration | Office | 87 | 47 | $20.20 | $1,757 |
| 96367 Intravenous Infusion, Hydration | Office | 86 | 55 | $20.32 | $1,748 |
| 96417 Chemotherapy Administration | Office | 64 | 51 | $44.37 | $2,839 |
By year: 2022 $1.5M for 60,811 services; 2023 $1.4M for 72,212 services; 2024 $848K for 34,167 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 390 | 261 | $8.65 | $3,374 |
Medicare prescription drug claims, 2024
In 2024, the drug Nancy L Bartlett prescribed most often to Medicare patients was Acyclovir, with 464 prescriptions and refills. In total Nancy L Bartlett wrote 2,596 Medicare prescriptions that cost $7.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 464 | 719 | 114 | $5,358 |
| Brukinsa Zanubrutinib | 164 | 164 | 20 | $2.1M |
| Prednisone Generic | 133 | 144 | 53 | $293 |
| Calquence Acalabrutinib Maleate | 131 | 131 | 16 | $1.9M |
| Prochlorperazine Maleate Generic | 81 | 81 | 56 | $1,487 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 71 | 96 | 24 | $235 |
| Gabapentin Generic | 71 | 82 | 15 | $1,131 |
| Omeprazole Generic | 67 | 126 | 27 | $607 |
| Levothyroxine Sodium Generic | 64 | 123 | 14 | $450 |
| Ondansetron Hcl Generic | 61 | 63 | 43 | $346 |
| Famotidine Generic | 48 | 80 | 12 | $279 |
| Trazodone Hcl Generic | 47 | 73 | 12 | $270 |
| Jaypirca Pirtobrutinib | 46 | 46 | Under 11 | $1.0M |
| Eliquis Apixaban | 43 | 55 | 12 | $32K |
| Potassium Chloride Generic | 35 | 51 | Under 11 | $409 |
Brand drugs: 659 claims; generic drugs: 1,919 claims; opioid claims: 53.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nancy L Bartlett $16K ($559 in general payments such as food, travel and fees and $16K for research) from 10 companies. The largest payer was Pfizer Inc. with $8,940.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.